RESUMEN
Plasmacytoid dendritic cells (pDC), the major interferon-producing cell type found in human blood, have been implicated in the pathogenesis of systemic lupus erythematosus (SLE). Previous studies in SLE have shown substantial deviations from normal in this minor but immunologically important leukocyte population. Many of the lupus patients studied were receiving corticosteroids. To determine the effects of steroid administration on pDC in healthy adults, four volunteers were given prednisone, 15-30 mg daily, for 4 days. Both counts of pDC, and their ability to produce IFN-alpha were significantly reduced (P = 0.02 and 0.004, respectively) during steroid administration, and rapidly recovered after discontinuation of the hormones. The overall reduction in pDC-derived IFN appeared to be attributable to falls of both number of circulating cells and of IFN produced per pDC. The effects observed with pDC were comparable in magnitude but opposite in direction to that observed for granulocytes. In contrast other blood leukocytes were little affected during steroid therapy.
Asunto(s)
Corticoesteroides/farmacología , Linfocitos T CD4-Positivos/inmunología , Células Dendríticas/efectos de los fármacos , Prednisona/farmacología , Adulto , Células Dendríticas/citología , Humanos , Técnicas In Vitro , Interferón-alfa/biosíntesis , Interferón-alfa/sangre , Lupus Eritematoso Sistémico/sangre , Lupus Eritematoso Sistémico/etiología , Lupus Eritematoso Sistémico/inmunología , Persona de Mediana Edad , Valores de ReferenciaRESUMEN
Increased frequency and severity of infections in the elderly have been taken as indicative of declining immune function. Dendritic cells (DCs), the most important antigen-presenting cells, play a central role in initiating and modulating immune responses. One type, DC2, arises from precursor plasmacytoid DCs (pDCs), a rare population of circulating blood cells, whose hallmark function is rapid and copious production of interferon-alpha (IFN-alpha) upon microbial challenge. We found significant decreases of the circulating pDCs during ageing in healthy adult humans, as defined both by flow cytometry and IFN-alpha generation. Mean pDC/mm3 in peripheral blood declined from 7.8 for the youngest age group (18-39 years) to 4.2 for the oldest (60-91 years; P = 0.017). IFN-alpha generation declined similarly, from 3537 to 1201 IU/ml, respectively (P = 0.006). There was also a slight decline over the age range in the amount of IFN generated per pDC (slope = -0.0087; P = 0.046). CD4+ T cells decreased by approximately 20% over the same age range (P = 0.001), while there was no change in the total lymphocyte or monocyte counts.
Asunto(s)
Envejecimiento/inmunología , Células Dendríticas/inmunología , Interferón-alfa/biosíntesis , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Envejecimiento/sangre , Envejecimiento/patología , Recuento de Linfocito CD4 , Células Dendríticas/citología , Femenino , Humanos , Leucocitos Mononucleares/citología , Leucocitos Mononucleares/inmunología , Recuento de Linfocitos , Masculino , Persona de Mediana EdadRESUMEN
Glucocorticoids are strongly immunosuppressive and are associated with reactivation of some intracellular infections. The plasmacytoid dendritic cell is a rare blood mononuclear cell detected through its production of IFN-alpha in response to herpes simplex virus and by surface immunophenotyping. We here report that steroid administration results in a decrease of IFN-alpha generation of approximately 25-fold, accompanied by reduction in circulating plasmacytoid dendritic cell numbers. Both parameters return to normal within days after steroid cessation.
Asunto(s)
Corticoesteroides/farmacología , Células Dendríticas/inmunología , Inmunosupresores/farmacología , Interferón-alfa/biosíntesis , Leucocitos Mononucleares/inmunología , Células Dendríticas/citología , Células Dendríticas/efectos de los fármacos , Humanos , Leucocitos Mononucleares/citología , Leucocitos Mononucleares/efectos de los fármacosRESUMEN
OBJECTIVES: To quantify the effect of HIV infection and HIV-suppressive therapy on interferon-alpha (IFN-alpha) production by human blood mononuclear cells; to compare, in parallel, effects on CD4+ T-cell numbers; and to ascertain the relationship of these interferon and CD4 parameters to resistance to opportunistic infections. DESIGN: Serial studies of 294 unselected patients with HIV infection during therapy, with outcomes analysis. METHODS: Determination of IFN generation by blood mononuclear cells via bioassay, and T-lymphocyte subset analysis via flow cytometry; serial studies of individual patients; linear regression and chi2 contingency table analysis. RESULTS: HIV burden is inversely related to interferon-alpha generation, much as it is to CD4+ T-cell counts. Both of these recover during HIV-suppressive therapy. Reconstitution of IFN-alpha generation to levels commensurate with protection against opportunistic infection occurs prior to similar restoration of CD4 counts. In the outcomes analyses, such immune reconstitution was associated with protection from recurrent or new opportunistic infection. Conversely, viral suppression without such immunologic recovery was not protective against opportunistic infection. CONCLUSIONS: Rapidly responding IFN-alpha generating cells appear to participate in resistance to opportunistic intracellular infection. Recovery of IFN-alpha generation may be an early marker of immune reconstitution in AIDS.
Asunto(s)
Fármacos Anti-VIH/uso terapéutico , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/inmunología , VIH-1/fisiología , Interferón-alfa/biosíntesis , Infecciones Oportunistas Relacionadas con el SIDA/inmunología , Infecciones Oportunistas Relacionadas con el SIDA/prevención & control , Recuento de Linfocito CD4 , Linfocitos T CD4-Positivos/inmunología , Células Dendríticas/inmunología , Femenino , Infecciones por VIH/virología , Humanos , Leucocitos Mononucleares/inmunología , Masculino , ARN Viral/sangre , Carga ViralRESUMEN
Interferons (IFNs) are the most important cytokines in antiviral immune responses. "Natural IFN-producing cells" (IPCs) in human blood express CD4 and major histocompatibility complex class II proteins, but have not been isolated and further characterized because of their rarity, rapid apoptosis, and lack of lineage markers. Purified IPCs are here shown to be the CD4(+)CD11c- type 2 dendritic cell precursors (pDC2s), which produce 200 to 1000 times more IFN than other blood cells after microbial challenge. pDC2s are thus an effector cell type of the immune system, critical for antiviral and antitumor immune responses.
Asunto(s)
Células Dendríticas/inmunología , Interferón Tipo I/biosíntesis , Interferón-alfa/biosíntesis , Ligando de CD40 , Linaje de la Célula , Separación Celular , Células Cultivadas , Células Dendríticas/citología , Células Dendríticas/ultraestructura , Humanos , Interferón-alfa/genética , Interferón beta/biosíntesis , Interferón beta/genética , Interleucina-3/farmacología , Leucocitos Mononucleares/inmunología , Glicoproteínas de Membrana/farmacología , Orgánulos/ultraestructura , ARN Mensajero/genética , ARN Mensajero/metabolismo , Simplexvirus/inmunología , Células Madre/citología , Células Madre/inmunologíaRESUMEN
BACKGROUND: Systolic blood pressure is well known to increase significantly with age and is strongly correlated with stroke and coronary artery disease. We and other investigators have reported a low prevalence of hypertension in subgroups of patients with HIV infection. In the present study, we examined an ambulatory population of patients with HIV infection to determine whether in the outpatient setting they may lack an age-related increase in systolic blood pressure. METHODS: In an ambulatory outpatient practice, medical records of 178 consecutive patients with HIV infection and those of 200 control subjects were examined. Systolic and diastolic blood pressure and other clinical and laboratory variables were recorded. Scatter plots were generated to compare age with systolic blood pressure. Spearman rank correlation analysis was carried out to determine the relationship between systolic blood pressure and age and other variables. RESULTS: Patients ranged in age from 13 to 69 years. There was only a very slight increase (which did not achieve statistical significance) in systolic blood pressure with aging in the patients with HIV infection, in contrast to the control population, in which an age-related increase in systolic blood pressure was seen that was comparable to published Framingham data. Mean systolic blood pressure for the group as a whole was 118.2 +/- 1.1 mm Hg. Mean serum albumin was 4.2 +/- 0.04 g/dL and was only slightly diminished in older patients. Mean serum cholesterol was 176.8 +/- 3.4 mg/dL and this bore no relationship to aging. More advanced stages of HIV infection also did not correlate with the lack of age-associated systolic hypertension. CONCLUSION: The present population of ambulatory patients infected with HIV seem to lack an age-related increase in systolic blood pressure; this may be caused by such variables as autonomic dysfunction or factors that may attenuate the development of atherosclerosis.
Asunto(s)
Presión Sanguínea , Infecciones por VIH/fisiopatología , Pacientes Ambulatorios , Adolescente , Adulto , Factores de Edad , Anciano , Atención Ambulatoria , Femenino , Infecciones por VIH/sangre , Humanos , Hipertensión/fisiopatología , Masculino , Persona de Mediana Edad , Factores Sexuales , SístoleAsunto(s)
Infecciones por VIH/diagnóstico , Infecciones por VIH/virología , VIH-1 , ARN Viral/análisis , Carga Viral/efectos adversos , Síndrome de Inmunodeficiencia Adquirida/diagnóstico , Síndrome de Inmunodeficiencia Adquirida/virología , Recuento de Linfocito CD4 , Progresión de la Enfermedad , Femenino , Infecciones por VIH/clasificación , Humanos , Masculino , Pronóstico , SobrevivientesRESUMEN
We report the case of a patient with acquired immunodeficiency syndrome (AIDS) who developed nephrotic syndrome and progressive renal failure mimicking human immunodeficiency virus (HIV)-associated focal segmental glomerulosclerosis (FSGS) who required initiation of hemodialysis and was found on renal biopsy to have membranous nephropathy. Hepatitis B and C serologies were negative. Although she required hemodialysis, she was treated with prednisone and experienced a progressive decline in her serum creatinine from 10.1 mg/dL to 1.9 mg/dL, which permitted the discontinuation of hemodialysis. After she abruptly discontinued prednisone, her creatinine level increased to 4.8 mg/dL, and she experienced marked worsening of her nephrotic syndrome. Resumption of prednisone resulted in normalization of serum creatinine and reduction in urine protein excretion. No adverse effects of prednisone occurred during this time. She remains off of hemodialysis for 1 year with a serum creatinine level of 1.0 mg/dL and urine protein excretion of 0.4 g/d. Although most patients with HIV infection, nephrotic-range proteinuria, and renal failure have FSGS, a minority may have membranous nephropathy. Although typically not a steroid-responsive lesion in the setting of advanced renal failure, membranous nephropathy may be a highly steroid-responsive lesion in the HIV-infected patient, and treatment may help avert the need for dialysis in a patient population that generally has a poor outcome on dialysis.
Asunto(s)
Síndrome de Inmunodeficiencia Adquirida/complicaciones , Antiinflamatorios/uso terapéutico , Glomerulonefritis Membranosa/diagnóstico , Glomerulonefritis Membranosa/tratamiento farmacológico , Fallo Renal Crónico/tratamiento farmacológico , Prednisona/uso terapéutico , Adulto , Diagnóstico Diferencial , Femenino , Glomerulonefritis Membranosa/complicaciones , Glomerulonefritis Membranosa/patología , Glomerulonefritis Membranosa/virología , Glomeruloesclerosis Focal y Segmentaria/diagnóstico , Humanos , Fallo Renal Crónico/etiología , Fallo Renal Crónico/patología , Diálisis RenalRESUMEN
In a clinical trial involving asymptomatic, HIV-seropositive subjects treated with either the HIV-1 immunogen (an inactivated, gp120-depleted HIV-1 virus in incomplete Freund's adjuvant) or an adjuvant control, we examined the relationship between changes in the percentage of CD4 cells over time and early clinical markers of HIV disease progression. Subjects who had an early clinical event were more likely to have a greater decline in the percentage of CD4 cells than those subjects who did not have a clinical event (p = 0.054). The greatest decline in CD4 percentage occurred within 10 weeks prior to a clinical event (mean 11% decrease from baseline). Subjects from the quartile with the greatest decline in CD4 percentage had a fivefold greater risk of having a clinical event than subjects from the quartile with the second largest decline (p = 0.045). These results demonstrate a relationship between changes in the percentage of CD4 cells and early clinical events. Further validation of this association may be useful in clinical monitoring and in evaluating therapies to treat HIV infection.
Asunto(s)
Vacunas contra el SIDA/uso terapéutico , Linfocitos T CD4-Positivos/inmunología , Seropositividad para VIH/inmunología , Complejo SIDA Demencia/complicaciones , Adyuvantes Inmunológicos , Biomarcadores , Recuento de Linfocito CD4 , Candidiasis Bucal/complicaciones , Estudios de Cohortes , Progresión de la Enfermedad , Método Doble Ciego , Estudios de Seguimiento , Seropositividad para VIH/complicaciones , Seropositividad para VIH/terapia , Infecciones por Herpesviridae/complicaciones , Humanos , Leucoplasia Vellosa/complicaciones , Enfermedades del Sistema Nervioso Periférico/complicaciones , Sarcoma de Kaposi/complicaciones , Vacunas de Productos Inactivados/uso terapéuticoRESUMEN
Rifabutin, a macrophage-penetrating lipophilic rifamycin, has a long half-life and activity in vitro against Mycobacterium avium complex (MAC). Preliminary studies of patients with AIDS and those with AIDS-related complex defined dose-limiting toxic effects (arthralgia/arthritis and uveitis) and suggested that rifabutin alone might reduce the incidence of MAC infections. Two double-blind, randomized, placebo-controlled trials involving 1,100 subjects confirmed the safety and efficacy of low doses of rifabutin; this therapy halved the rate of MAC bacteremia and significantly reduced symptoms associated with disseminated MAC infections. Subsequent experience with rifabutin as prophylaxis for and treatment of MAC infections has generally supported its safety profile. Emergence of drug-resistant MAC causing infection in patients receiving rifabutin therapy has not been reported. Interactions with azoles and macrolides increase blood levels of rifabutin and have led to the development of uveitis in certain patients. Studies of the cost-effectiveness of rifabutin prophylaxis for MAC infection suggest that it is comparable with other preventive interventions employed in clinical practice.
Asunto(s)
Infecciones Oportunistas Relacionadas con el SIDA/tratamiento farmacológico , Antibacterianos/farmacología , Infección por Mycobacterium avium-intracellulare/tratamiento farmacológico , Rifabutina/farmacología , Antibacterianos/efectos adversos , Recuento de Linfocito CD4 , Análisis Costo-Beneficio , Farmacorresistencia Microbiana , Humanos , Infección por Mycobacterium avium-intracellulare/fisiopatología , Rifabutina/efectos adversos , Uveítis/inducido químicamenteRESUMEN
Progressive loss of CD4+ T lymphocytes, accompanied by opportunistic infections characteristic of the acquired immune deficiency syndrome, ahs been reported in the absence of any known etiology. The pathogenesis of this syndrome, a subset of idiopathic CD4+ T lymphocytopenia (ICL), is uncertain. We report that CD4+ T cells from seven of eight ICL patients underwent accelerated programmed cell death, a process facilitated by T cell receptor cross-linking. Apoptosis was associated with enhanced expression of Fas and Fas ligand in unstimulated cell populations, and partially inhibited by soluble anti-Fas mAb. In addition, apoptosis was suppressed by aurintricarboxylic acid, an inhibitor of calcium-dependent endonucleases and proteases, in cells from four of seven patients, The in vivo significance of these findings was supported by three factors: the absence of accelerated apoptosis in persons with stable, physiologic CD4 lymphopenia without clinical immune deficiency; detection of serum antihistone H2B autoantibodies, one consequence of DNA fragmentation, in some patients; and its selectivity, with apoptosis limited to the CD4 population in some, and occurring among CD8+ T cells predominantly in those individuals with marked depletion of both CD4+ T lymphocytes linked to clinical immune suppression have evidence for accelerated T cell apoptosis in vitro that may be pathophysiologic and amenable to therapy with apoptosis inhibitors.
Asunto(s)
Apoptosis , Linfocitos T CD4-Positivos/patología , Síndromes de Inmunodeficiencia/etiología , Linfocitopenia-T Idiopática CD4-Positiva/etiología , Adulto , Ácido Aurintricarboxílico/farmacología , Secuencia de Bases , Proteína Ligando Fas , Femenino , Citometría de Flujo , Humanos , Síndromes de Inmunodeficiencia/complicaciones , Masculino , Glicoproteínas de Membrana , Persona de Mediana Edad , Datos de Secuencia Molecular , Transducción de Señal/efectos de los fármacos , Linfocitopenia-T Idiopática CD4-Positiva/complicaciones , Tamoxifeno/farmacología , Receptor fasRESUMEN
Patients with hairy cell leukemia (HCL) are susceptible to opportunistic intracellular infections, suggesting defects in cellular immunity. Prior studies have indicated an association between failure of IFN-alpha generation by peripheral blood mononuclear cells (MNC) and susceptibility to such infections. We here present results on IFN-alpha generation in HCL patients pre- and post-therapy. Prior to treatment with 2-chloro-2'-deoxyadenosine (CdA), MNC from 24 HCL patients with active disease produced little or not IFN-alpha (geometric mean < 40 IU/ml) compared with controls (n = 140, geometric mean 1730 IU/ml, p < 0.0005). After treatment with CdA, IFN-alpha generation was studied in 16 patients, with a geometric mean value of 650 IU/ml (p < 0.0005 compared with pre-CdA levels). The severe depression of IFN-alpha generation improved progressively following CdA therapy-induced clinical remission. We propose that deficiency of IFN-alpha production may play a role in the susceptibility to intracellular infections of patients with active HCL.
Asunto(s)
Cladribina/uso terapéutico , Interferón-alfa/biosíntesis , Leucemia de Células Pilosas/tratamiento farmacológico , Infecciones Oportunistas/inmunología , Adulto , Anciano , Susceptibilidad a Enfermedades , Femenino , Humanos , Leucemia de Células Pilosas/complicaciones , Leucemia de Células Pilosas/inmunología , Leucocitos Mononucleares/metabolismo , Activación de Linfocitos , Masculino , Persona de Mediana Edad , Infecciones Oportunistas/complicaciones , Inducción de Remisión , Esplenectomía , Subgrupos de Linfocitos TRESUMEN
Respiratory papillomas, caused by human papillomaviruses, are benign tumors that recur following removal. We evaluated immune function and major histocompatibility complex (MHC) phenotype and expression in these patients. MHC-independent immune function appeared normal. The frequency of peripheral blood MHC class II phenotypes was highly enriched for DQ3 and DR11, one split of DR5. Class I MHC antigen expression on papilloma tissue was markedly reduced. Together, these phenomena may facilitate papillomavirus evasion of the cellular immune response.
Asunto(s)
Antígenos HLA-DQ/análisis , Antígenos de Histocompatibilidad Clase I/análisis , Papiloma/inmunología , Neoplasias del Sistema Respiratorio/inmunología , Adulto , Niño , Preescolar , Susceptibilidad a Enfermedades/inmunología , Femenino , Humanos , Inmunofenotipificación , Masculino , Recurrencia Local de Neoplasia , Estudios RetrospectivosRESUMEN
In humans with advanced human immunodeficiency virus (HIV) infection, an interferon-alpha (IFN-alpha) response by a specialized blood mononuclear cell to herpes simplex virus (HSV) in vitro is associated with resistance to opportunistic infections. A cell type of unknown lineage, designated the natural IFN-producing cell (NIPC), has been identified preliminarily as the source of these IFNs and may have a role in other host defense functions. Earlier studies suggested the existence of analogous HSV-responsive cell populations in mice. The role specifically of IFN-alpha in the murine system, however, has not been characterized. Using IFN bioassay and neutralization with antisera against Type I IFNs and IFN-beta, we have defined the types and sources of IFNs produced by mice in response to in vivo and in vitro challenge with UV-inactivated HSV. After intraperitoneal inoculation with HSV, BALB/c and C57Bl/6 strains produced characteristically different levels of serum IFNs that appeared principally to be IFN-alpha. The response of mononuclear cells from these mice differed from that of the intact mouse. Isolated cells from bone marrow and spleen released detectable IFNs much later than did whole animals, and the IFNs produced by marrow, spleen, and peritoneal cells were usually neutralized by the anti-IFN-beta. Only bone marrow cells produced detectable amounts of IFN-alpha. Both intact mice and their cells became refractory to restimulation with similar kinetics.
Asunto(s)
Herpesvirus Humano 1/inmunología , Interferón-alfa/biosíntesis , Animales , Líquido Ascítico/inmunología , Médula Ósea/inmunología , Células de la Médula Ósea , Herpesvirus Humano 1/efectos de la radiación , Cinética , Células L , Leucocitos Mononucleares/inmunología , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Rayos UltravioletaRESUMEN
Nemaline-rod myopathy was recently reported in eight young males infected with human immune deficiency virus type 1 (HIV-1). A 41-year-old woman had a 2-year history of progressive proximal-muscle weakness. Muscle biopsy demonstrated the presence of nemaline rods, predominantly in type 1 fibers. She was coinfected with HIV-1 and HTLV-2, as evidenced by positive polymerase chain reaction and serology. There was no lymphopenia or CD4 lymphopenia, despite an abnormal T-cell subset ratio, high CD8 count, skin anergy, and depressed in vitro response to mitogens. This case raises the possibility that dual infection may play a role in the pathogenesis of the rare nemaline-rod myopathies of HIV-infected patients.
Asunto(s)
Infecciones por VIH/complicaciones , VIH-1 , Infecciones por HTLV-II/complicaciones , Enfermedades Musculares/etiología , Enfermedades Musculares/patología , Adulto , Femenino , Infecciones por VIH/patología , Infecciones por HTLV-II/patología , Humanos , Miofibrillas/patologíaRESUMEN
We have previously demonstrated that in vitro production of interferon-alpha (IFN-alpha) in response to herpes simplex virus (HSV) by peripheral blood mononuclear cells PBMCs from patients infected with the human immunodeficiency virus (HIV-1) decreases dramatically with disease progression, with extremely low levels of IFN-alpha preceding and predictive of opportunistic infections. Natural killer (NK) lysis, however, was found to decay later in disease and often was within normal limits even when IFN-alpha production was severely compromised. The NK lysis of HSV-infected fibroblasts (HSV-FS) is dependent on an HLA-DR+ accessory cell (AC) population that shares the phenotype of the predominant IFN-alpha-producing cell (IPC) population. To determine whether there is a correlation between AC activity and IFN-alpha production in these patients, we tested the ability of PBMCs from AIDS patients to provide AC help to NK cells from heterologous donors. While NK cells were highly sensitive to gamma irradiation, AC activity was relatively radioresistant. Therefore, NK cells from healthy donors were depleted of HLA-DR+ ACs and added to irradiated PBMCs from either healthy or AIDS donors to test for the function of ACs in the irradiated populations. Irradiated cells from AIDS patients were found to provide normal AC activity despite decreased IFN-alpha production in the majority of the patients. We failed to observe NK augmenting activity in supernatants of irradiated PBMCs from IFN-deficient patients that had been stimulated with HSV-FS.(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
Síndrome de Inmunodeficiencia Adquirida/inmunología , Células Presentadoras de Antígenos/inmunología , Interferón-alfa/biosíntesis , Células Asesinas Naturales/inmunología , Células Presentadoras de Antígenos/efectos de la radiación , Antígenos HLA-DR/sangre , Humanos , Células Asesinas Naturales/efectos de la radiación , Simplexvirus/inmunologíaRESUMEN
There have been three published cases of acquired immunodeficiency in which no evidence for infection with human immunodeficiency virus (HIV) types 1 and 2 was found. We have identified five other individuals, from the New York City area (four who have known risk factors for HIV infection), with profound CD4 depletion and clinical syndromes consistent with definitions of the acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. None had evidence of HIV-1, 2 infection, as judged by multiple serologies over several years, standard viral co-cultures for HIV p24 Gag antigen, and proviral DNA amplification by polymerase chain reaction.
Asunto(s)
Síndrome de Inmunodeficiencia Adquirida/sangre , Seropositividad para VIH/fisiopatología , Adulto , Anciano , Antígenos CD4/aislamiento & purificación , Femenino , Humanos , Masculino , Persona de Mediana Edad , Factores de RiesgoRESUMEN
We studied the tolerance of humans to rifabutin, a rifamycin with antimycobacterial and in vitro anti-HIV activity. Sixteen subjects with AIDS-related complex were treated for 4-66 weeks with stepwise increasing oral doses of rifabutin from 300 to 2400 mg/day. The highest dose attained was twice that previously reported for humans. Serum and cerebrospinal fluid levels of drug were detected by high-pressure liquid chromatography. A reversible syndrome of arthritis/arthralgia, not previously described, was seen in most (nine out of 10) of those given doses exceeding 1050 mg/day. Uveitis and aphthous stomatitis developed at doses of approximately 1800 mg in two of those with joint manifestations. Typical manifestations of Reiter's syndrome were not seen in any patient. An orange-tan skin pigmentation was almost universal. Other toxicities resembled those previously associated with rifampin. Serum levels did not approach those found to inhibit HIV significantly in vitro. No consistent antiviral or immunological effects were observed; even at the highest doses, rifabutin did not appear to inhibit cellular immunity. Rifabutin was well tolerated at daily doses blow 1 g.
Asunto(s)
Complejo Relacionado con el SIDA/tratamiento farmacológico , Artritis/inducido químicamente , Rifamicinas/efectos adversos , Adulto , Antígenos CD4/análisis , Relación Dosis-Respuesta a Droga , VIH-1/efectos de los fármacos , Humanos , Activación de Linfocitos/efectos de los fármacos , Masculino , Persona de Mediana Edad , Trastornos de la Pigmentación/inducido químicamente , Rifabutina , Rifamicinas/metabolismo , Uveítis/inducido químicamenteRESUMEN
Clinical evaluations of hypouricemia in patients with the acquired immunodeficiency syndrome (AIDS) have shown that it is a common disorder resulting from defective renal handling of uric acid. We prospectively studied renal urate handling in 23 patients and reviewed the records of 73 consecutive patients with AIDS or AIDS-related complex (ARC), who were seen in our AIDS clinic between March 1985 and April 1988, to determine the incidence, significance, and, when possible, the cause of hypouricemia. Hypouricemia was defined as serum urate less than or equal to 0.18 mmol/L (3 mg/dL). Renal clearance studies were performed in 23 patients, 10 hypouricemic and 13 nonhypouricemic. Eight patients (six with hypouricemia) underwent central venous pressure (CVP) monitoring, which was performed for clinical signs and symptoms of extracellular volume depletion. Fourteen (eight with hypouricemia) had daily urine urate measured. Hypouricemia was found in 21 (21.9%) of 96 patients. It was more common in females and intravenous (IV) drug abusers, and was associated with more opportunistic illnesses, particularly mycobacterium avium intracellulare (MAI) and cytomegalovirus (CMV) infections. Hypouricemia occurred in three patients with ARC and 18 patients with AIDS and was associated with cerebral atrophy in all 12 hypouricemic and 14 of 28 nonhypouricemic patients who had cranial computed tomography (CT) scans. During a comparable follow-up period, 71.4% of the hypouricemic as compared with 38.7% of nonhypouricemic patients died. Eleven developed hypouricemia as outpatients. Fractional excretion of uric acid (FEua) was elevated in the eight patients with CVP less than 1 cm of water, and in 10 of 10 with and nine of 13 without hypouricemia, despite CVP less than 1 cm water in eight.(ABSTRACT TRUNCATED AT 250 WORDS)